HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Trump’s TPP Withdrawal Dashes Hopes For Cosmetics Regulatory Alignment

This article was originally published in The Rose Sheet

Executive Summary

President Trump’s executive order to pull out of the Trans-Pacific Partnership trade deal is intended to help American workers, but for the cosmetics industry, the move likely marks a foiled opportunity.

You may also be interested in...



Trans-Pacific Partnership Lives: US Out, But Cosmetics Annex Still In

Eleven countries have salvaged and rebranded the international trade deal abandoned by President Donald Trump in early 2017, with a signing ceremony slated for March 8 in Chile. The CPTPP retains much of the original TPP, including a cosmetics annex to promote harmonization around regulatory best practices

Cosmetics Reg Reform Ill-Situated As Trump, FDA Explore 'Burden Reduction'

Any movement to advance proposed cosmetics reform legislation could be seen as running counter to President Trump's executive orders earlier this year, which now have FDA centers seeking "broad public comment" on how to achieve "meaningful burden reduction."

With TPP Demise, PCPC Sets Harmonization Goals Closer To Home

Following President Trump’s decision to pull out of the Trans-Pacific Partnership agreement, the Personal Care Products Council sets its sights on renegotiation of the North American Free Trade Agreement.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS109059

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel